Все публикации

0:00:53

H1 and Q2 2024 Financial Results

0:01:00

The Believers – Delivering greener, more equitable healthcare (Mohamed, Egypt)

0:01:09

How do TCR-Ts differ from CAR-T cell therapies?

0:02:36

The next chapter for Healthy Heart Africa

0:01:50

Oncology R&D strategy - attacking cancer from multiple angles

0:02:25

CoSolve 2023 announces collaboration with the Moss group

0:04:46

Oncology evolution: Value assessment to keep pace with science

0:02:06

Our commitment to advancing CVRM treatment

0:02:31

Bronchiectasis, the unknown respiratory disease

0:02:36

AZ Forest: committed to support biodiversity and human health

0:01:01

Antibody drug conjugates: science and imagination linked by purpose

0:03:43

Kate’s story

0:02:54

Lean digital technologies to support our smart factories.

0:02:54

Fostering a culture of lifelong learning

0:04:18

Top tips for applying to AstraZeneca’s R&D Postdoc Challenge

0:00:59

Detecting Cancer Earlier with Circulating Tumour DNA (ctDNA)

0:03:50

Living with lupus: Jeanette’s story

0:03:41

Explore our locations across North America

0:06:54

Developing next-generation oligonucleotide therapeutics

0:01:15

Computational Pathology: revolutionising cancer therapies and diagnostics

0:07:29

Your treatment options after a Lung Cancer diagnosis

0:04:26

How we’re inspiring change by embracing our differences

0:04:31

Your Lung Cancer healthcare team

0:02:12

Your Lung Cancer diagnosis